Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(103 sites)

United States

AKDHC Medical Research ServicesLLC, Phoenix, Arizona

Kaiser Permanente Fontana, Fontana, California

Univ Calif Irvine, Irvine, California

Ronald Reagan UCLA Medical Center, Los Angeles, California

Loma Linda University, San Bernardino, California

Olive View UCLA Medical Center, Sylmar, California

University of Colorado Denver, Aurora, Colorado

Royal Research Corp, Hollywood, Florida

Mayo Clinic Jacksonville, Jacksonville, Florida

Nephrology Associates Of Central FL, Orlando, Florida

Florida Kidney Physicians, Riverview, Florida

Nep Assoc of Northern Illinois, Hinsdale, Illinois

Wichita Community Clcl Onco Program, Wichita, Kansas

Ochsner Health System, New Orleans, Louisiana

Johns Hopkins Hospital, Baltimore, Maryland

Brigham and Womens Hosp Harvard Med School, Boston, Massachusetts

Mayo Clinic Rochester, Rochester, Minnesota

University of Nebraska Medical Center, Omaha, Nebraska

Stony Brook Internists PC, East Setauket, New York

Cleveland Clinic Foundation, Cleveland, Ohio

Temple University, Philadelphia, Pennsylvania

Allegheny Health Network, Pittsburgh, Pennsylvania

Dallas Nephrology Associates, Dallas, Texas

Prolato Clinical Research Center, Houston, Texas

Virginia Commonwealth University, Richmond, Virginia

Argentina

Novartis Investigative Site, Rosario, Santa Fe Province

Novartis Investigative Site, San Luis

Novartis Investigative Site, Santa Fe

Brazil

Novartis Investigative Site, Salvador, Estado de Bahia

Novartis Investigative Site, Belo Horizonte, Minas Gerais

Novartis Investigative Site, Juiz de Fora, Minas Gerais

Novartis Investigative Site, Barretos, São Paulo

Novartis Investigative Site, São Paulo, São Paulo

Novartis Investigative Site, Salvador

China

Novartis Investigative Site, Nanning, Guangxi

Novartis Investigative Site, Wuhan, Hubei

Novartis Investigative Site, Shenyang, Liaoning

Novartis Investigative Site, Yinchuan, Ningxia

Novartis Investigative Site, Beijing

Novartis Investigative Site, Shenzhen

Colombia

Novartis Investigative Site, Barranquilla, Atlántico

Novartis Investigative Site, Bogota, Cundinamarca

Novartis Investigative Site, Bucaramanga, Santander Department

Novartis Investigative Site, Montería

France

Novartis Investigative Site, Marseille

Novartis Investigative Site, Nantes

Novartis Investigative Site, Paris

Novartis Investigative Site, Strasbourg

Germany

Novartis Investigative Site, Munich, Bavaria

Novartis Investigative Site, Ludwigshafen, Germany

Novartis Investigative Site, Frankfurt am Main, Hesse

Novartis Investigative Site, Braunschweig, Lower Saxony

Novartis Investigative Site, Cologne, North Rhine-Westphalia

Novartis Investigative Site, Berlin

Novartis Investigative Site, Mainz

Hong Kong

Novartis Investigative Site, Hong Kong, Hong Kong

Hungary

Novartis Investigative Site, Debrecen, Hajdu Bihar Megye

Novartis Investigative Site, Budapest

Novartis Investigative Site, Szeged

India

Novartis Investigative Site, Ahmedabad, Gujarat

Novartis Investigative Site, Kozhikode, Kerala

Novartis Investigative Site, New Delhi, National Capital Territory of Delhi

Novartis Investigative Site, Vellore, Tamil Nadu

Novartis Investigative Site, Hyderabad, Telangana

Novartis Investigative Site, Lucknow, Uttar Pradesh

Novartis Investigative Site, Puducherry

Israel

Novartis Investigative Site, Ashkelon

Novartis Investigative Site, Jerusalem

Novartis Investigative Site, Ramat Gan

Malaysia

Novartis Investigative Site, Kuantan, Pahang

Novartis Investigative Site, Taiping, Perak

Novartis Investigative Site, Selangor Darul Ehsan

Mexico

Novartis Investigative Site, Tampico, Tamaulipas

Novartis Investigative Site, Mérida, Yucatán

Novartis Investigative Site, Aguascalientes

Novartis Investigative Site, Veracruz

Philippines

Novartis Investigative Site, Makati City, National Capital Region

Novartis Investigative Site, Iloilo City

Novartis Investigative Site, Quezon

Portugal

Novartis Investigative Site, Carnaxide

Novartis Investigative Site, Coimbra

Novartis Investigative Site, Lisbon

Novartis Investigative Site, Porto

Novartis Investigative Site, Vila Nova de Gaia

Puerto Rico

FDI Clinical Research, San Juan

Singapore

Novartis Investigative Site, Singapore, Singapore

Spain

Novartis Investigative Site, Port de Sagunt, Valencia

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Ciudad Real

Novartis Investigative Site, Madrid

Novartis Investigative Site, Seville

Turkey (Türkiye)

Novartis Investigative Site, Ankara, Bilkent-Cankaya

Novartis Investigative Site, Istanbul, Fatih

Novartis Investigative Site, Kayseri, Melikgazi

Novartis Investigative Site, Bursa, Nilufer

Novartis Investigative Site, Ankara, Yenimahalle

Novartis Investigative Site, Mersin, Yenisehir

United Kingdom

Novartis Investigative Site, Cambridge

Novartis Investigative Site, Leicester

View full record on ClinicalTrials.gov

Trial locations(103 sites)

Interested in joining?